IL-27 rs153109 polymorphism increases the risk of colorectal cancer in Chinese Han population

OncoTargets and Therapy

Volumn 8, Issue , 2015, Pages 1493-1497

  Lyu, Shixu ^a   Ye, Lechi ^a   Wang, Ouchen ^a   Huang, Guanli ^a   Yang, Fan ^a   Liu, Yehuan ^a   Dong, Siyang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

CRC; IL 27; Polymorphism

Indexed keywords

EID: 84934282386     PISSN: None     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S80255     Document Type: Article

References (21)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
2. Arends MJ. Pathways of colorectal carcinogenesis. Appl Immunohistochem Mol Morphol. 2013;21(2):97-102.
3. Jia WH, Zhang B, Matsuo K, et al. Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer. Nat Genet. 2013;45(2):191-196.
4. Hu Y, Sun Z, Zhang A, Zhang J. SMAD7 rs12953717 polymorphism contributes to increased risk of colorectal cancer. Tumour Biol. 2014;35(1):695-699.
5. Liu L, Zhong R, Wei S, et al. The Leptin Gene Family and Colorectal Cancer:Interaction with Smoking Behavior and Family History of Cancer. PLoS One. 2013;8(4):e60777.
6. Tagawa M. Cytokine therapy for cancer. Curr Pharm Des. 2000;6(6):681-699.
7. Pflanz S, Timans JC, Cheung J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity. 2002;16(6):779-790.
8. Nagai H, Oniki S, Fujiwara S, et al. Antitumor activities of interleukin- 27 on melanoma. Endocr Metab Immune Disord Drug Targets. 2010;10(1):41-46.
9. Engel MA, Neurath MF. Anticancer Properties of the IL-12 Family - Focus on Colorectal Cancer. Curr Med Chem. 2010;17(29):3303-3308.
10. Hisada M, Kamiya S, Fujita K, et al. Potent Antitumor Activity of Interleukin-27. Cancer Res. 2004;64(3):1152-1156.
11. Morishima N, Owaki T, Asakawa M, Kamiya S, Mizuguchi J, Yoshimoto T. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. J Immunol. 2005;175(3):1686-1693.
12. Tao YP, Wang WL, Li SY, et al. Associations between polymorphisms in IL-12A, IL-12B, IL-12R b1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer. J Cancer Res Clin Oncol. 2012;138(11):1891-1900.
13. Zhang Z, Zhou B, Wu Y, et al. Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population. Immunogenetics. 2014;66(2):85-92.
14. Wei YS, Lan Y, Luo B, Lu D, Nong HB. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma. Mol Carcinog. 2009;48(8):751-757.
15. Peng Q, Qin X, He Y, et al. Association of IL27 gene polymorphisms and HBV-related hepatocellular carcinoma risk in a Chinese population. Infect Genet Evol. 2013;16:1-4.
16. Zhao B, Meng LQ, Huang HN, Pan Y, Xu QQ. A novel functional polymorphism, 16974 A/C, in the interleukin-12-3′untranslated region is associated with risk of glioma. DNA Cell Biol. 2009;28(7):335-341.
17. Chae SC, Li CS, Kim KM, et al. Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population. J Hum Genet. 2007;52(4):355-361.
18. Huang N, Liu L, Wang XZ, et al. Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population. DNA Cell Biol. 2008;27(9):527-531.
19. Li CS, Zhang Q, Lee KJ, et al. Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean population. J Gastroenterol Hepatol. 2009;24(10):1692-1696.
20. Zhao P, Dai M, Chen W, Li N. Cancer trends in China. Jpn J Clin Oncol. 2010;40(4):281-285.
21. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273(5281):1516-1517.